"/> Invitrogen™ Peptide synthétique HINT1 humain | B-LABO France

Invitrogen™ Peptide synthétique HINT1 humain

Réf. : BL-RE-176307Réf. fabricant : 15328950 50 μg
137,00 € HT

Synthetic Peptide

Gene ID (Entrez)
3094
Espèces
Human
Méthode de purification
purified
Numéro d’adhésion
P49773
Nom usuel
Human HINT1
Marque
Invitrogen

HINT1 Synthetic Peptide, PEP-0733, from Invitrogen.

Histidine triad nucleotide-binding protein 1 (HINT1) is a member of the histidine triad (HIT) protein family, a group of small nucleotide-binding and -hydrolyzing proteins. HINT1 interacts with several diverse proteins and has been suggested to have tumor suppressive activities. HINT1 catalyzes the hydrolysis of adenosine 5'-monophoramidate substrates such as AMP-morpholidate, but its enzymatic function does not appear to play a role in its tumor suppression. Recent experiments demonstrate that HINT1 forms a complex with POSH and JNK in vivo, inhibiting AP-1 activity and the phosphorylation of c-Jun, and this action could contribute to the tumor suppressor activity of HINT1. Other studies raise the possibility of HINT1 as a candidate gene for schizophrenia.

Caractéristiques techniques

MarqueInvitrogen
Réf. B-LABOBL-RE-176307
Réf. fabricant15328950
Gene ID (Entrez)3094
EspècesHuman
Méthode de purificationpurified
Numéro d’adhésionP49773
Nom usuelHuman HINT1
Concentration200 μg/mL
Contenu et stockage-20°C
FormatLiquid
FormulePBS with 0.1% BSA and 0.02% sodium azide; pH 7.2
À utiliser avec (application)Blocking Assay, Control
Symbole de gène(s)HINT1
LyophiliséNo
Conservateur0.02% sodium azide
Type de produitPeptide
Quantité50 μg
État réglementaireRUO - research use only
Tampon de stockagePBS
Une question, une configuration particulière ?
Contactez-nous pour un devis.